{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:14:12Z","timestamp":1788552852604,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K18907"],"award-info":[{"award-number":["JP20K18907"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012030","name":"Yakult Honsha Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jim.2026.114108","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:12:50Z","timestamp":1788016370000},"page":"114108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hybridoma-based generation of a functional IgM antibody targeting the 160-loop of influenza B virus haemagglutinin"],"prefix":"10.1016","volume":"551","author":[{"given":"Shizuma","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Odagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2026.114108_bb0005","first-page":"1","article-title":"Understanding IgM structure and biology to engineer new antibody therapeutics","author":"Buchner","year":"2025","journal-title":"BioDrugs"},{"key":"10.1016\/j.jim.2026.114108_bb0010","doi-asserted-by":"crossref","first-page":"e00705","DOI":"10.1128\/jvi.00705-25","article-title":"Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses","volume":"99","author":"Carlock","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2026.114108_bb0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jim.2010.09.022","article-title":"A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells","volume":"363","author":"Charles","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2026.114108_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9673(01)94018-X","article-title":"Comparison of mono Q, superose-6, and ABx fast protein liquid chromatography for the purification of IgM monoclonal antibodies","volume":"444","author":"Chen","year":"1988","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jim.2026.114108_bb0025","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s41587-020-0732-8","article-title":"COVID-19 antibodies on trial","volume":"38","author":"DeFrancesco","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jim.2026.114108_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nbt.2009.03.017","article-title":"Monoclonal antibody purification with hydroxyapatite","volume":"25","author":"Gagnon","year":"2009","journal-title":"New Biotechnol."},{"key":"10.1016\/j.jim.2026.114108_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108790","article-title":"Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2","volume":"34","author":"Gasser","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jim.2026.114108_bb0040","article-title":"IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2","volume":"219","author":"Hale","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2026.114108_bb0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0042-6822(84)90384-2","article-title":"Antigenic structure of the hemagglutinin of influenza virus B\/Hong Kong\/8\/73 as determined from gene sequence analysis of variants selected with monoclonal antibodies","volume":"139","author":"Hovanec","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.jim.2026.114108_bb0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev-immunol-032414-112315","article-title":"Exploiting mucosal immunity for antiviral vaccines","volume":"34","author":"Iwasaki","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jim.2026.114108_bb0055","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.drudis.2022.03.004","article-title":"Methodological advances in the design of peptide-based vaccines","volume":"27","author":"Kalita","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jim.2026.114108_bb0060","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.exphem.2006.05.006","article-title":"Development of human\u2013human hybridoma from anti-Her-2 peptide\u2013producing B cells in immunized NOG mouse","volume":"34","author":"Kametani","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jim.2026.114108_bb0065","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0264-410X(00)00367-4","article-title":"Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies","volume":"19","author":"Kawana","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2026.114108_bb0070","article-title":"Structure, function, and therapeutic use of IgM antibodies","volume":"9","author":"Keyt","year":"2020","journal-title":"Antibodies (Basel, Switzerland)"},{"key":"10.1016\/j.jim.2026.114108_bb0075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution","volume":"342","author":"Koel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jim.2026.114108_bb0080","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41586-021-03673-2","article-title":"Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants","volume":"595","author":"Ku","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jim.2026.114108_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1620\/tjem.171.327","article-title":"Production of a human monoclonal antibody to a synthetic peptide by active in vivo immunization using a SCID mouse grafted with human lymphocytes","volume":"171","author":"Kudo","year":"1993","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jim.2026.114108_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-024-01847-8","article-title":"Enhanced potency of an IgM-like nanobody targeting conserved epitope in SARS-CoV-2 spike N-terminal domain","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jim.2026.114108_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jim.2026.114108_bb0100","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1128\/JVI.73.9.7343-7348.1999","article-title":"Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature","volume":"73","author":"McCullers","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2026.114108_bb0105","series-title":"Mucosal immunol","year":"2015"},{"key":"10.1016\/j.jim.2026.114108_bb0110","article-title":"Isotype conversion of staphylococcal-specific IgG into IgM broadens the reactivity to other bacterial pathogens","volume":"6","author":"Muts","year":"2025","journal-title":"Cell Rep Med."},{"key":"10.1016\/j.jim.2026.114108_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0166-0934(99)00015-4","article-title":"Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies","volume":"79","author":"Nakagawa","year":"1999","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jim.2026.114108_bb0120","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JCM.43.8.4212-4214.2005","article-title":"Variation of the conserved neutralizing epitope in influenza B virus Victoria group isolates in Japan","volume":"43","author":"Nakagawa","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2026.114108_bb0125","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/JCM.44.4.1564-1566.2006","article-title":"Discovery of the neutralizing epitope common to influenza B virus Victoria group isolates in Japan","volume":"44","author":"Nakagawa","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2026.114108_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"Nakamura","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jim.2026.114108_bb0135","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s007050050399","article-title":"Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism","volume":"143","author":"Nerome","year":"1998","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jim.2026.114108_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127750","article-title":"Polymyxin B as a novel mucosal adjuvant for the intranasal whole inactivated influenza vaccine","volume":"64","author":"Odagiri","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2026.114108_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1769","article-title":"BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-\u03baB pathway","volume":"3","author":"Pone","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jim.2026.114108_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jviromet.2016.04.013","article-title":"Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus","volume":"235","author":"Sasaki","year":"2016","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jim.2026.114108_bb0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7150\/thno.28434","article-title":"An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency","volume":"9","author":"Shen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jim.2026.114108_bb0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jim.2026.114108_bb0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2567.2004.01868.x","article-title":"Sequence-specific binding of normal serum immunoglobulin M to exposed protein C-termini","volume":"112","author":"Sokoloff","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jim.2026.114108_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.immunol.26.021607.090248","article-title":"Mechanism and regulation of class switch recombination","volume":"26","author":"Stavnezer","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jim.2026.114108_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101207","article-title":"Broad neutralizing antibody-based strategies to tackle influenza","volume":"53","author":"Sun","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jim.2026.114108_bb0180","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jpba.2009.11.003","article-title":"A comparative characterization of dipentameric (IgM)2 and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use","volume":"51","author":"Tark\u00f6y","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jim.2026.114108_bb0185","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1073\/pnas.1502374112","article-title":"A broadly neutralizing human monoclonal antibody is effective against H7N9","volume":"112","author":"Tharakaraman","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jim.2026.114108_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2026.114108_bb0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2026.114108_bb0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10616-006-9032-5","article-title":"Anoikis-resistant MDCK cells carrying susceptibilities to TNF-\u03b1 and verotoxin that are suitable for influenza virus cultivation","volume":"52","author":"Tsutsumi","year":"2006","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jim.2026.114108_bb0205","first-page":"202","article-title":"On the possibility of lipid-induced regulation of conformation and immunogenicity of influenza a virus H1\/N1 hemagglutinin as antigen of TI-complexes","volume":"24","author":"Vorobieva","year":"2014","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.jim.2026.114108_bb0210","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JVI.02477-07","article-title":"Crystal structure of unliganded influenza B virus hemagglutinin","volume":"82","author":"Wang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2026.114108_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jim.2026.114108_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exppara.2016.03.011","article-title":"Generation and characterization of monoclonal antibodies specific for 18 kDa antigen from Taenia solium cysticerci","volume":"166","author":"Zhang","year":"2016","journal-title":"Exp. Parasitol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175926000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175926000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:38:26Z","timestamp":1788550706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175926000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S0022175926000840"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2026.114108","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybridoma-based generation of a functional IgM antibody targeting the 160-loop of influenza B virus haemagglutinin","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2026.114108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114108"}}